Virginia Tech has developed a university-wide cancer research strategy to create and expand synergies among more than 30 existing research teams at work finding new ways to prevent, quickly diagnose, and treat cancers, officials announced today.

The effort will increase cooperation and connections among Virginia Tech’s growing cancer research community, help recruit additional cancer researchers, provide access to state-of-the-art shared research resources, foster relationships with institutions and agencies recognized as world leaders in cancer treatment and research, and enhance the already substantial cancer research funding at the university.

“Virginia Tech has dozens of dedicated, smart people working in research labs developing innovations for patients and families in their struggles with this disease, but we usually talk about their work on an individual level,” said Michael Friedlander, vice president for health sciences and technology at Virginia Tech. “By looking at the totality of Virginia Tech’s efforts, the optics reveal a broad, diverse landscape of faculty members and expertise across colleges, centers, and institutes being applied to solve the health issues and social problems caused by cancer.”

Virginia Tech has 22 active cancer research awards from the National Cancer Institute of the National Institutes of Health (NIH) with an annual value of $4.3 million.

To learn more, check out the whole article below.

https://vtnews.vt.edu/articles/2019/10/cancerplan-fralinbiomedical-101619.html